Treatment of pediatric anxiety disorders

Amy Rapp, Alice Dodds, John T. Walkup, Moira Rynn*

*Corresponding author for this work

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.

Original languageEnglish (US)
Pages (from-to)52-61
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1304
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Pediatrics
Anxiety Disorders
Riluzole
Separation Anxiety
Cycloserine
Memantine
Obsessive-Compulsive Disorder
Cognitive Therapy
Post-Traumatic Stress Disorders
Anticonvulsants
Innovation
Medication
Social Phobia

Keywords

  • Anxiety
  • Cognitive behavioral therapy
  • Pediatric
  • Pharmacotherapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Rapp, Amy ; Dodds, Alice ; Walkup, John T. ; Rynn, Moira. / Treatment of pediatric anxiety disorders. In: Annals of the New York Academy of Sciences. 2013 ; Vol. 1304, No. 1. pp. 52-61.
@article{0dc5ca78c5ee40da83e59129439bb5f5,
title = "Treatment of pediatric anxiety disorders",
abstract = "This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.",
keywords = "Anxiety, Cognitive behavioral therapy, Pediatric, Pharmacotherapy",
author = "Amy Rapp and Alice Dodds and Walkup, {John T.} and Moira Rynn",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/nyas.12318",
language = "English (US)",
volume = "1304",
pages = "52--61",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

Treatment of pediatric anxiety disorders. / Rapp, Amy; Dodds, Alice; Walkup, John T.; Rynn, Moira.

In: Annals of the New York Academy of Sciences, Vol. 1304, No. 1, 01.01.2013, p. 52-61.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment of pediatric anxiety disorders

AU - Rapp, Amy

AU - Dodds, Alice

AU - Walkup, John T.

AU - Rynn, Moira

PY - 2013/1/1

Y1 - 2013/1/1

N2 - This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.

AB - This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.

KW - Anxiety

KW - Cognitive behavioral therapy

KW - Pediatric

KW - Pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=84888408021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888408021&partnerID=8YFLogxK

U2 - 10.1111/nyas.12318

DO - 10.1111/nyas.12318

M3 - Article

VL - 1304

SP - 52

EP - 61

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -